Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disparities in Survival of Head and Neck Cancer in the Hispanic Population: Systematic-Review and Meta-analysis.
Marrero-Gonzalez AR, Nanu DP, Nguyen SA, Brennan EA, Albergotti WG, Chera BS, Harper JL, Kaczmar JM, Kejner AE, Newman JG, Skoner JM, Graboyes EM. Marrero-Gonzalez AR, et al. Among authors: kaczmar jm. Otolaryngol Head Neck Surg. 2025 Jan 5. doi: 10.1002/ohn.1113. Online ahead of print. Otolaryngol Head Neck Surg. 2025. PMID: 39756015 Review.
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance.
Roof SA, Jabalee J, Rettig EM, Chennareddy S, Ferrandino RM 2nd, Chen S, Posner MR, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Del Vecchio Fitz C, Hanna GJ. Roof SA, et al. Among authors: kaczmar jm. Oral Oncol. 2024 Aug;155:106874. doi: 10.1016/j.oraloncology.2024.106874. Epub 2024 Jun 14. Oral Oncol. 2024. PMID: 38878355
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
Hanna GJ, Roof SA, Jabalee J, Rettig EM, Ferrandino R, Chen S, Posner MR, Misiukiewicz KJ, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Gupta P, Kuperwasser C, Del Vecchio Fitz C, Berger BM. Hanna GJ, et al. Among authors: kaczmar jm. Clin Cancer Res. 2023 Oct 13;29(20):4306-4313. doi: 10.1158/1078-0432.CCR-23-1478. Clin Cancer Res. 2023. PMID: 37566241 Free PMC article.
Systematic review of neuroendocrine carcinomas of the oropharynx.
Froehlich MH, Shih MC, Shehee L, Kompelli AR, Aylward A, Nguyen SA, Kaczmar JM, Nathan CA, Day T, Neskey DM. Froehlich MH, et al. Among authors: kaczmar jm. Head Neck. 2022 Jul;44(7):1725-1736. doi: 10.1002/hed.27055. Epub 2022 Apr 18. Head Neck. 2022. PMID: 35437851 Review.
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
Wise-Draper TM, Gulati S, Palackdharry S, Hinrichs BH, Worden FP, Old MO, Dunlap NE, Kaczmar JM, Patil Y, Riaz MK, Tang A, Mark J, Zender C, Gillenwater AM, Bell D, Kurtzweil N, Mathews M, Allen CL, Mierzwa ML, Casper K, Jandarov R, Medvedovic M, Lee JJ, Harun N, Takiar V, Gillison M. Wise-Draper TM, et al. Among authors: kaczmar jm. Clin Cancer Res. 2022 Apr 1;28(7):1345-1352. doi: 10.1158/1078-0432.CCR-21-3351. Clin Cancer Res. 2022. PMID: 35338369 Free PMC article. Clinical Trial.
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma.
Knochelmann HM, Horton JD, Liu S, Armeson K, Kaczmar JM, Wyatt MM, Richardson MS, Lomeli SH, Xiong Y, Graboyes EM, Lentsch EJ, Hornig JD, Skoner J, Stalcup S, Spampinato MV, Garrett-Mayer E, O'Quinn EC, Timmers CD, Romeo MJ, Wrangle JM, Young MRI, Rubinstein MP, Day TA, Lo RS, Paulos CM, Neskey DM. Knochelmann HM, et al. Among authors: kaczmar jm. Cell Rep Med. 2021 Oct 19;2(10):100426. doi: 10.1016/j.xcrm.2021.100426. eCollection 2021 Oct 19. Cell Rep Med. 2021. PMID: 34755137 Free PMC article.
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.
Graboyes EM, Sterba KR, Li H, Warren GW, Alberg AJ, Calhoun EA, Nussenbaum B, McCay J, Marsh CH, Osazuwa-Peters N, Neskey DM, Kaczmar JM, Sharma AK, Harper J, Day TA, Hughes-Halbert C. Graboyes EM, et al. Among authors: kaczmar jm. JCO Oncol Pract. 2021 Oct;17(10):e1512-e1523. doi: 10.1200/OP.20.00943. Epub 2021 Mar 10. JCO Oncol Pract. 2021. PMID: 33689399 Free PMC article.
19 results